Altitude Acquisition Corp. (ALTU) to Combine with Vesicor Therapeutics in $70M Deal
Altitude (NASDAQ:ALTU) has entered into a definitive agreement to combine with Vesicor Therapeutics for $70 million in equity consideration. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. Transaction Overview Altitude has about $10.3 million in its current trust after seeing
Read More
To access this post, you must purchase 1 - User: Monthly Plan.